MeiraGTx Holdings (MGTX) Change in Accured Expenses (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Change in Accured Expenses of $8.7 million for Q4 2025, up 185.39% on a QoQ basis from -$10.2 million in Q3 2025, and down 6.95% year-over-year from $9.4 million in Q4 2024.
MeiraGTx Holdings (MGTX) Change in Accured Expenses (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Change in Accured Expenses history runs 9 years deep, the most recent figure standing at $8.7 million for Q4 2025.
- Quarterly Change in Accured Expenses fell 6.95% year-over-year to $8.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.4 million (up 131.59% YoY) and the FY2025 annual result came in at $4.4 million, up 131.59% from the prior year.
- Change in Accured Expenses was $8.7 million for Q4 2025 at MeiraGTx Holdings, up from -$10.2 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $13.5 million in Q4 2023 and bottomed at -$24.2 million in Q1 2024.
- A 5-year average of -$313105.3 and a median of $1.6 million in 2024 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses soared 11956.52% — and 2025, when it slumped 748.48%.
- MeiraGTx Holdings' Change in Accured Expenses stood at $5.0 million in 2021, then slumped by 51.98% to $2.4 million in 2022, then surged by 460.92% to $13.5 million in 2023, then slumped by 30.62% to $9.4 million in 2024, then fell by 6.95% to $8.7 million in 2025.
- Business Quant data shows MGTX's Change in Accured Expenses at $8.7 million in Q4 2025, -$10.2 million in Q3 2025, and $9.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -16.82 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -16.74 Mn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 8.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.74 Mn |
| Dec 31, 2025 | 8.74 Mn |
| Sep 30, 2025 | -10.23 Mn |
| Sep 30, 2025 | -10.23 Mn |
| Jun 30, 2025 | 9.49 Mn |
| Jun 30, 2025 | 9.49 Mn |
| Mar 31, 2025 | -3.59 Mn |
| Mar 31, 2025 | -3.59 Mn |
| Dec 31, 2024 | 9.39 Mn |
| Dec 31, 2024 | 9.39 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Jun 30, 2024 | -697,000.00 |
| Jun 30, 2024 | -697,000.00 |
| Mar 31, 2024 | -24.23 Mn |
| Mar 31, 2024 | -24.23 Mn |
| Dec 31, 2023 | 13.54 Mn |
| Dec 31, 2023 | 13.54 Mn |
| Sep 30, 2023 | 3.32 Mn |
| Sep 30, 2023 | 3.32 Mn |